Market cap roughly 1.156 trillion* DDK (~$182 billion, USD/DKK 6.3408).
Operating profits DKK billion
2021 ~58
2022 ~74
2023 ~102
2024 ~128
2025 ~127 (~20 billion USD)
Novo is currently valued less than 1/5 of Lilly’s market cap.
Lilly’s operating profit for 2025 was 26.3 billion USD. Revenue guidance for 2026 indicates midpoint growth of 25%.
*4,465,000,000 shares at 259 DDK
Disclaimer: This is not investment advice. For entertainment purposes only.